Publications by authors named "Debbie Albin"

Claim this Profile
T
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Erin K McCreary, J Ryan Bariola, Tami E Minnier, Richard J Wadas, Judith A Shovel, Debbie Albin

Contemp Clin Trials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
David T Huang, Erin K McCreary, J Ryan Bariola, Tami E Minnier, Richard J Wadas, Debbie Albin

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A learning health system approach to the COVID-19 pandemic: System-wide changes in clinical practice and 30-day mortality among hospitalized patients.
Erin K McCreary, Kevin E Kip, J Ryan Bariola, Mark Schmidhofer, Tami Minnier, Debbie Albin

Learn Health Syst· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
Erin K McCreary, J Ryan Bariola, Richard J Wadas, Judith A Shovel, Mary Kay Wisniewski, Debbie Albin

JAMA Netw Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Erin K McCreary, J Ryan Bariola, Tami Minnier, Richard J Wadas, Judith A Shovel, Debbie Albin

Contemp Clin Trials· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
Thomas J Woltemate, Richard J Wadas, Erin K McCreary, Ryan Bariola, Tami Minnier, Debbie Albin

J Am Coll Emerg Physicians Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
David T Huang, Erin K McCreary, J Ryan Bariola, Richard J Wadas, Kevin E Kip, Debbie L Albin

Trials· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis